Through their leadership, the organisation enabled the most consequential transition of the 20th century: from an age of ...

The have had to manage the balance between seeking to influence the president and remaining an honest broker. As Berger put it, “You have to be perceived by your colleagues as an honest ...

In Deep Dive: Market Access II, Eric Low shares his views on why hurdles remain to new drug access – and how medical research charities can lead the way in multi-stakeholder research ...